Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Mutation in blood coagulation factor V associated with resistance to activated protein C
19942.9k citationsRogier M. Bertina, Bobby P. C. Koeleman et al.Natureprofile →
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
1993990 citationsTed Koster, Jan P. Vandenbroucke et al.The Lancetprofile →
Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis
1995873 citationsTed Koster, Jan P. Vandenbroucke et al.The Lancetprofile →
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
1996819 citationsMartin den Heijer, Ted Koster et al.New England Journal of Medicineprofile →
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) [see comments]
1995791 citationsTed Koster, Jan P. Vandenbroucke et al.profile →
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
1994771 citationsJan P. Vandenbroucke, Ted Koster et al.The Lancetprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Ted Koster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted Koster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted Koster more than expected).
This network shows the impact of papers produced by Ted Koster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted Koster. The network helps show where Ted Koster may publish in the future.
Co-authorship network of co-authors of Ted Koster
This figure shows the co-authorship network connecting the top 25 collaborators of Ted Koster.
A scholar is included among the top collaborators of Ted Koster based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Ted Koster. Ted Koster is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Heijer, Martin den, Ted Koster, Henk J. Blom, et al.. (1996). Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis. New England Journal of Medicine. 334(12). 759–762.819 indexed citations breakdown →
Koster, Ted, Jan P. Vandenbroucke, F. R. Rosendaal, E Briët, & Andrew D. Blann. (1995). Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. The Lancet. 345(8943). 152–155.873 indexed citations breakdown →
16.
Bertina, Rogier M., Bobby P. C. Koeleman, Ted Koster, et al.. (1994). Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369(6475). 64–67.2926 indexed citations breakdown →
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.